We are updating our Privacy Policy and Terms and Conditions to help you clearly understand how your personal information is collected, stored and managed. Learn More
Menu Back toIncorporating-Real-World-Evidence-into-Medical-Responses

DIA 2018 Global Annual Meeting

The DIA 2018 Global Annual Meeting brings together thousands of innovators from around the globe.

Using Patient-Centric Outcomes to Engage Patients in Shared Treatment Decision Making

    Session Chair(s)
      Sara  Doshi, PharmD

      Sara Doshi, PharmD

      • Director, Medical Information Strategy and Capabilities, GMI
      • Eli Lilly and Company, United States
    This session will briefly review for the audience what are patient-reported outcomes and real world evidence. Speakers will then review the types of data that can be gathered, analyzed, and then communicated to patients and healthcare providers to assist in treatment decisions. Examples of how this data has been effectively communicated in a variety of channels will be provided.
    Learning Objective : Identify types of patient-relevant evidence collected in the clinical development and the real-world settings; Describe how patient-reported outcomes are generated, evaluated, and communicated to assist in informed treatment decision making; Discuss strategies to educate medical information departments on the value of real world evidence and patient-reported outcomes and incorporated this data in communications.
      Emily  Freeman, PhD, MSc

      How Can Patient-Reported Data Inform Shared Treatment Decision-Making?

      Emily Freeman, PhD, MSc

      • Director, Patient Centered Outcomes
      • AbbVie, Inc., United States
      Agnes  Hong, PharmD

      Generating Patient-Reported Outcomes Evidence to Provide Meaningful Insights for Treatment Decision-Making

      Agnes Hong, PharmD

      • Associate Outcomes Research Scientist, Oncology
      • Genentech, A Member of the Roche Group, United States
      Linda  Wang, PharmD

      Bringing Patient-Centric Outcomes to Customers

      Linda Wang, PharmD

      • Medical Communications Leader
      • Genentech, A Member of the Roche Group, United States